InvestmentAug 6, 2026, 08:10 PM
BlossomHill Therapeutics Prices Upsized IPO at $16.00/Share, Raising $150M
AI Summary
BlossomHill Therapeutics, Inc. announced the pricing of its upsized initial public offering of 9,375,000 shares of common stock at $16.00 per share. The offering is expected to generate gross proceeds of $150.0 million for the clinical-stage biopharmaceutical company. The shares are anticipated to begin trading on The Nasdaq Global Select Market under the ticker symbol "BLSM" on August 7, 2026, with the closing expected on August 10, 2026.
Key Highlights
- Priced upsized initial public offering of 9,375,000 shares of common stock.
- Public offering price set at $16.00 per share.
- Expected gross proceeds of $150.0 million from the offering.
- Underwriters granted 30-day option to purchase up to an additional 1,406,250 shares.
- Shares expected to begin trading on Nasdaq Global Select Market on August 7, 2026.
- Offering expected to close on August 10, 2026, subject to customary conditions.
- J.P. Morgan, Leerink Partners, and Guggenheim Securities are lead book-running managers.
Price Impact
More from BLSM